They write
While NASDAQ listed Jazz Pharmaceuticals managed to weather the storm thanks to a solid Q1 financial update, it was the Aquis Exchange which saw some of the most dramatic developments this week.
Ananda Developments continued its upward trajectory following last week’s hiring spree, while CBD operators Love Hemp and Yooma Wellness were both forced to suspend trading on the platform altogether.
Love Hemp
The CBD brand told investors that it had been ‘temporarily suspended’ on the exchange because its advisors, Peterhouse Capital Limited, decided to split from the company.
While Love Hemp said it expects to announce new advisors ‘shortly’, it also announced that an unnamed investor had ‘failed to make payment’ of £1.2m in Ordinary Shares.
The investor is understood to have subscribed the money for 120,000,000 shares at a price of 1p per share as part of the company’s fundraise on February 8 2022.
This represents more than half of the £2m it secured in February during the raise, which saw Peterhouse Capital and H&P Advisory Limited act as brokers.
Read full article
EU Cannabis Stocks Review: Love Hemp & Yooma Wellness Both See Their Shares Suspended
